MARKET

PFE

PFE

Pfizer
NYSE

Real-time Quotes | Nasdaq Last Sale

39.58
+0.39
+1.00%
After Hours: 39.50 -0.08 -0.20% 19:58 05/07 EDT
OPEN
39.05
PREV CLOSE
39.19
HIGH
39.87
LOW
39.05
VOLUME
33.81M
TURNOVER
--
52 WEEK HIGH
43.08
52 WEEK LOW
29.96
MARKET CAP
220.78B
P/E (TTM)
23.72
1D
5D
1M
3M
1Y
5Y
UPDATE 1-EU has not yet ordered more AstraZeneca vaccines, says internal market commissioner
reuters.com · 1h ago
U.S. support for IP rights waiver of COVID-19 vaccines meets resistance in EU
Prominent EU countries have reiterated the opposition to the U.S.-backed moves to waive patent protections for COVID-19 vaccines.German Chancellor Angela Merkel who previously voiced her opposition to U.S. plans highlighted
Seekingalpha · 11h ago
UPDATE 1-SAfrica picks up first cases of coronavirus variant from India
reuters.com · 16h ago
U.S. wants COVID vaccine patent waiver to benefit world, not boost China biotech
reuters.com · 17h ago
BRIEF-U.S. CDC Says Delivered 329,840,055 Doses Of Covid-19 Vaccine As Of May 8 Versus 327,124,625 Doses As Of May 7
reuters.com · 19h ago
U.S. administers 257.3 mln doses of COVID-19 vaccines –CDC
reuters.com · 19h ago
EU agrees potential 1.8 billion-dose purchase of Pfizer jab
The European Union cemented its support for Pfizer-BioNTech and its novel COVID-19 vaccine technology Saturday by agreeing to a massive contract extension for a potential 1.8 billion doses through 2023.
MarketWatch · 19h ago
Benzinga's Bulls And Bears Of The Week: Apple, Amazon, Kroger, Netflix, Pfizer And More
Benzinga has examined the prospects for many of investors' favorite stocks over the past week. The past week's bullish calls included a couple of FAANG stocks and a company that just took a big hit.
Benzinga · 21h ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of PFE. Analyze the recent business situations of Pfizer through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 22 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average PFE stock price target is 41.99 with a high estimate of 53.00 and a low estimate of 36.00.
EPS
Institutional Holdings
Institutions: 2.86K
Institutional Holdings: 3.72B
% Owned: 66.71%
Shares Outstanding: 5.58B
TypeInstitutionsShares
Increased
1.24K
109.27M
New
280
18.24M
Decreased
897
226.16M
Sold Out
109
22.50M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.86%
Pharmaceuticals & Medical Research
+1.04%
Key Executives
Chairman/Chief Executive Officer/Director
Albert Bourla
President
John Young
Chief Financial Officer/Executive Vice President
Frank D'Amelio
Chief Financial Officer/Executive Vice President
Frank D'amelio
Corporate Executive
Angela Hwang
Executive Vice President/Chief Technology Officer
Lidia Fonseca
Executive Vice President/Chief Compliance Officer/Chief Risk Officer
Rady Johnson
Executive Vice President/General Counsel
Douglas Lankler
Executive Vice President
Sally Susman
Chief Scientific Officer
Mikael Dolsten
Lead Director/Independent Director
Shantanu Narayen
Independent Director
Ronald Blaylock
Independent Director
Susan Desmond-Hellmann
Independent Director
Joseph Echevarria
Independent Director
Scott Gottlieb
Independent Director
Helen Hobbs
Independent Director
Susan Hockfield
Independent Director
W. Don Cornwell
Independent Director
Dan Littman
Independent Director
Wyllie Cornwell
Independent Director
Suzanne Nora Johnson
Independent Director
James Quincey
Independent Director
James Smith
Declaration Date
Dividend Per Share
Ex-Div Date
04/22/2021
Dividend USD 0.39
05/06/2021
12/11/2020
Dividend USD 0.39
01/28/2021
09/24/2020
Dividend USD 0.38
11/05/2020
06/25/2020
Dividend USD 0.38
07/30/2020
04/23/2020
Dividend USD 0.38
05/07/2020
12/16/2019
Dividend USD 0.38
01/30/2020
09/24/2019
Dividend USD 0.36
11/07/2019
06/27/2019
Dividend USD 0.36
08/01/2019
04/25/2019
Dividend USD 0.36
05/09/2019
12/14/2018
Dividend USD 0.36
01/31/2019
09/27/2018
Dividend USD 0.34
11/08/2018
06/28/2018
Dividend USD 0.34
08/02/2018
04/26/2018
Dividend USD 0.34
05/10/2018
12/18/2017
Dividend USD 0.34
02/01/2018
09/27/2017
Dividend USD 0.32
11/09/2017
06/23/2017
Dividend USD 0.32
08/02/2017
04/28/2017
Dividend USD 0.32
05/10/2017
12/13/2016
Dividend USD 0.32
02/01/2017
09/23/2016
Dividend USD 0.3
11/08/2016
06/23/2016
Dividend USD 0.3
08/03/2016
04/28/2016
Dividend USD 0.3
05/11/2016
12/16/2015
Dividend USD 0.3
02/03/2016
09/25/2015
Dividend USD 0.28
11/04/2015
06/25/2015
Dividend USD 0.28
08/05/2015
04/23/2015
Dividend USD 0.28
05/06/2015
12/17/2014
Dividend USD 0.28
02/04/2015
10/24/2014
Dividend USD 0.26
11/05/2014
06/26/2014
Dividend USD 0.26
07/30/2014
04/25/2014
Dividend USD 0.26
05/07/2014
12/17/2013
Dividend USD 0.26
02/05/2014
10/25/2013
Dividend USD 0.24
11/06/2013
06/28/2013
Dividend USD 0.24
07/31/2013
About PFE
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.

Webull offers kinds of Pfizer Inc. stock information, including NYSE:PFE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PFE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PFE stock methods without spending real money on the virtual paper trading platform.